QT Imaging (QTI)
Builds FDA-cleared breast acoustic CT scanning and viewing software.
Something off on this page? Send us feedback.
Develops and commercializes the Breast Acoustic CT Scanner and QTviewer imaging software. The business operates as one reportable segment and also pursues scanner distribution and QTI Cloud SaaS subscriptions.
Develops and commercializes the Breast Acoustic CT Scanner, an FDA-cleared transmission-and-reflection ultrasonic 3D breast-imaging system. QTviewer provides viewing and analysis of the scanner's co-registered volumetric datasets and is designed for DICOM and PACS workflows.
The business has one operating and reportable segment centered on this scanner platform, and its product path remains concentrated rather than portfolio-driven. Commercialization depends on scanner distribution and, where applicable, QTI Cloud SaaS subscriptions; a Saudi agreement covers both. FDA clearance and a Category III CPT code scheduled to take effect in 2027 shape the product's route to use and reimbursement.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $11.0M · Total debt $4.3M · Total assets $30.6M · Shareholders' equity $2.2M
- Revenue
- $7.4M
- Operating income
- −$1.9M
- Net income
- −$11.1M
No dividends on record.
| Institutions | 22.30% | 3.26M shares | |
|---|---|---|---|
| 29 holders · as of Jun 30, 2026 | |||
| Insiders | 37.48% | 5.49M shares | |
| 9 holders · as of Aug 31, 2026 | |||
| Other | 40.22% | 5.89M shares | |
| remainder | |||
14.64M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
John C. Jr KlockInsiderdirector, 10 percent owner | 19.71% | 2.88M | filed Mar 24, 2026 |
Raluca DinuInsiderdirector, officer: Chief Executive Officer | 9.52% | 1.39M | filed Aug 31, 2026 |
Lynrock Lake LPInstitution | 7.60% | 1.11M | as of Jun 30, 2026 |
Alyeska Investment Group, L.P.Institution | 4.80% | 702,776 | as of Jun 30, 2026 |
James S. GreeneInsiderdirector | 4.32% | 631,582 | filed Mar 24, 2026 |
Insider tradesForm 4
No open-market trades in the last 12 months.
- GE HealthCare
Automated 3D breast-ultrasound platform for dense-tissue screening
- Philips (ADR)
Diagnostic-imaging supplier with ultrasound, MRI, and breast-care workflows
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| QT Imaging | $2.86 | +10.00% | $35.8M | — | — | 1.3 | +103.2% |
| GE HealthCare | $65.83 | −0.66% | $29.93B | 19.2 | 12.7 | 1.5 | +5.8% |
| Philips (ADR) | $24.67 | −1.22% | $24.41B | 18.9 | 12.8 | 1.2 | −2.8% |
| Median | 19.0 | 12.8 | 1.3 | +1.5% |